MedSurg and Neurotechnology sales were $3.7 billion, up 9.2%, with organic growth of 9.1%. Orthopaedics sales were $2.9 billion, up 5.7% as reported and 5.9% in constant currency.
Operating earnings were $21.2 million, compared with an operating loss of $60.2 million. Net earnings were $20.9 million, or $0.35 per diluted share, versus a net loss of $45.1 million, or $(0.80) per share, in the prior year quarter.
Net income was $100.7 million, an increase of $9.7 million from $91.0 million in fiscal 2025. Chairman and CEO Marc Stefanski said the year passed the $100 million mark, driven by margin improvement and a 39% increase in mortgage loan originations.
Diluted EPS grew 29.7% year over year, outpacing the 14.3% rise in net income on a calculated basis. The gap reflects a smaller share count, with weighted diluted shares at 41.1 million versus 46.5 million.
Gross merchandise value was $641.5 million, versus $519.8 million, which is about 23.4% higher on a calculated basis. Orders rose 15% to 1.02 million, and average order value climbed 8% to $629 from $584. Active buyers reached 1.152 million, up from 1.024 million.
Revenue reached $1.56 billion, up 20% reported and 16% organic year over year. CEO Khozema Shipchandler called it a great quarter driven by disciplined execution and broad-based strength across the product portfolio.
Gross profit rose to $12.5 million from $3.4 million, lifting gross margin by 730 basis points to 9.8%. REPREVE FiberRevenuewas $36.4 million, or 29% of net sales.
Income from operations was $32.8 million, compared with an operating loss of $117.4 million. The prior year quarter included $124.4 million of non-cashImpairmentcharges.
Sales were $1,509 million, up 7.5% from $1,404 million. Core sales rose 5.1%, with acquisitions adding 2.3% and currency 0.1%, and price increases contributed 2.3% to growth.Gross Profitwas $908 million, a margin of 60.2% compared with 60.1%.
Total revenues were $167.1 million, up $39.6 million from $127.5 million, or 31.0% on a calculated basis. OilRevenuegrew to $111.8 million from $84.1 million.